 NEW YORK, Nov. 02, 2020 GLOBE NEWSWIRE -- Delcath Systems, Inc. NASDAQ: DCTH, an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today announced management will participate in the Oppenheimer Fall MedTech Summit on Thursday, November 12, 2020. 